Loading clinical trials...
Loading clinical trials...
Factorial, Multicentric, Randomized Clinical Trial of Remdesivir and Immunotherapy in Combination With Dexamethasone for Moderate COVID-19 (the AMMURAVID Trial)
Conditions
Interventions
Baricitinib Oral Tablet [Olumiant]
Remdesivir
+1 more
Locations
21
Italy
Ospedali Riuniti delle Marche
Ancona, Italy
Ospedale Parini
Aosta, Italy
Ospedale SS Annunziata -Chieti
Chieti, Italy
Ospedale S Anna
Como, Italy
Ospedale di Ferrara
Ferrara, Italy
Ospedale di Firenze and Empoli
Florence, Italy
Start Date
April 6, 2021
Primary Completion Date
March 1, 2022
Completion Date
December 1, 2022
Last Updated
April 6, 2021
NCT04525716
NCT03188796
NCT06355232
NCT05191420
NCT04611243
NCT04678193
Lead Sponsor
ASST Fatebenefratelli Sacco
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions